Tenon Medical, Inc.

For the period ended Jun 30, 2025. Filed Aug 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 13, 2025

TNON$1.74-0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Operations and Comprehensive Loss

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except per share data)

	Three Months Ended June 30,		Six Months Ended June 30,
	2025	2024	2025	2024
Revenue	$564	$901	$1,290	$1,620
Cost of sales	319	431	722	680
Gross Profit	245	470	568	940
Operating Expenses
Research and development	503	708	1,194	1,377
Sales and marketing	1,119	1,448	2,766	2,829
General and administrative	1,480	2,186	3,142	4,112
Total Operating Expenses	3,102	4,342	7,102	8,318
Loss from Operations	(2,857)	(3,872)	(6,534)	(7,378)
Other Income (Expense)
Gain on investments	88	39	149	66
Interest expense	—	—	—	(34)
Other income (expense), net	—	7	—	(56)
Total Other Income (Expense), net	88	46	149	(24)
Net Loss	$(2,769)	$(3,826)	$(6,385)	$(7,402)
Net Loss Per Share of Common Stock
Basic and diluted	$(0.36)	$(8.16)	$(1.14)	$(17.92)
Weighted-Average Shares of Common Stock Outstanding
Basic and diluted	7,591	469	5,605	413
Consolidated Statements of Comprehensive Loss:
Net loss	$(2,769)	$(3,826)	$(6,385)	$(7,402)
Foreign currency translation adjustment	—	—	—	46
Total comprehensive loss	$(2,769)	$(3,826)	$(6,385)	$(7,356)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.